Shilpa Medicare Ltd - Announcement Under Regulation 30 Of The SEBI(LODR) Regulations.
17 Nov 2025
Shilpa announces the launch of NODUCATM for the first time in India to treat metabolic dysfunction associated fatty liver disease (MAFLD)
Source:
BSE India